Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease
Authors
Keywords
-
Journal
Immunotherapy
Volume 2, Issue 6, Pages 767-782
Publisher
Future Medicine Ltd
Online
2010-11-22
DOI
10.2217/imt.10.80
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid Imaging in Aging and Dementia: Testing the Amyloid HypothesisIn Vivo
- (2014) G. D. Rabinovici et al. BEHAVIOURAL NEUROLOGY
- Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
- (2012) David H. Cribbs CNS & Neurological Disorders-Drug Targets
- Neurotoxicity of β-Amyloid Protein: Oligomerization, Channel Formation and Calcium Dyshomeostasis
- (2012) Masahiro Kawahara CURRENT PHARMACEUTICAL DESIGN
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- 2010 Alzheimer's disease facts and figures
- (2010) Alzheimers & Dementia
- Immunotherapy with bapineuzumab lowers CSF tau protein levels in patients with Alzheimer's disease
- (2010) Kaj Blennow et al. Alzheimers & Dementia
- Modulation of tau pathology in tau transgenic models
- (2010) Jean-Pierre Brion et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
- (2010) Jessica M. Mc Donald et al. BRAIN
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
- (2010) James A. Duce et al. CELL
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
- (2010) V. Frisardi et al. Current Alzheimer Research
- β -Amyloid: A Disease Target or a Synaptic Regulator Affecting Age-Related Neurotransmitter Changes?
- (2010) E. Mura et al. CURRENT PHARMACEUTICAL DESIGN
- Bapineuzumab
- (2010) Geoffrey A Kerchner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- ADDLs and the signaling web that leads to Alzheimer’s disease
- (2010) Grant A. Krafft et al. NEUROPHARMACOLOGY
- Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport: Fig. 1
- (2010) Keith A. Vossel et al. SCIENCE
- Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies
- (2010) Takeshi Tabira TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Identification, characterization, and comparison of amino-terminally truncated Aβ 42 peptides in Alzheimer's disease brain tissue and in plasma from Alzheimer's patients receiving solanezumab immunotherapy treatment
- (2009) Ronald B. DeMattos et al. Alzheimers & Dementia
- Selection of an anti-Abeta antibody that binds various forms of Abeta and blocks toxicity both in vitro and in vivo
- (2009) Ryan J. Watts et al. Alzheimers & Dementia
- Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease
- (2009) Timothy Nicholas et al. Alzheimers & Dementia
- Drug development for Alzheimer's disease: Where are we now and where are we headed?
- (2009) Marwan N. Sabbagh American Journal Geriatric Pharmacotherapy
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
- (2009) John C. Morris et al. ARCHIVES OF NEUROLOGY
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease
- (2009) Francesco Panza et al. DRUGS & AGING
- Is passive immunization for Alzheimer's disease ‘alive and well’ or ‘dead and buried’?
- (2009) Gregory A Jicha EXPERT OPINION ON BIOLOGICAL THERAPY
- Vaccination with A -Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral A and Lowers Plaque Burden in APP Transgenic Mice
- (2009) P. Bach et al. JOURNAL OF IMMUNOLOGY
- A Immunotherapy: Intracerebral Sequestration of A by an Anti-A Monoclonal Antibody 266 with High Affinity to Soluble A
- (2009) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls
- (2009) N. M. Scheinin et al. NEUROLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- The Role of Apolipoprotein E in Alzheimer's Disease
- (2009) Jungsu Kim et al. NEURON
- S1-02-02: Natural human antibodies targeting amyloid aggregates in intravenous immunoglobulin
- (2008) Norman R. Relkin Alzheimers & Dementia
- P4-346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
- (2008) Eric R. Siemers et al. Alzheimers & Dementia
- Active and Passive Immunotherapy for Neurodegenerative Disorders
- (2008) David L. Brody et al. Annual Review of Neuroscience
- Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease
- (2008) Jung Won Youm et al. BIOTECHNOLOGY LETTERS
- Alzheimer Disease Pathology As a Host Response
- (2008) Rudy J. Castellani et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
- (2008) S. Schroeter et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Amyloid-β immunisation for Alzheimer's disease
- (2008) Thomas Wisniewski et al. LANCET NEUROLOGY
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse
- (2008) Peter Seubert et al. Neurodegenerative Diseases
- Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
- (2008) Michael Pride et al. Neurodegenerative Diseases
- Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy
- (2008) Nina Movsesyan et al. PLoS One
- Antibody-based approaches in Alzheimer’s research: safety, pharmacokinetics, metabolism, and analytical tools
- (2007) Peter Lichtlen et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search